Pharma Exec Faints at Oval Office 'Affordable' Drug Event
The Independent reports a pharma executive passed out in the Oval Office while standing behind Donald Trump for a "major announcement" on making GLP-1 drugs "more affordable." One might suggest the sheer weight of hypocrisy finally manifested physically. Pharmaceutical corporations systematically hike drug prices, making life-saving medication unaffordable for millions. For example, Novo Nordisk,
a major GLP-1 producer, reported a 31% operating profit growth in 2023, largely due to demand for these very drugs. This staged event, featuring the architects of inflated drug costs pretending to lower them, is the kind of political theater that makes 'affordability' a cruel joke for patients rationing insulin or skipping doses. Perhaps the executive was overwhelmed by the absurdity, or simply by
the prospect of admitting their industry's role in the crisis. How many Americans, struggling to afford their prescriptions, feel like passing out daily? One wonders if the White House has affordable GLP-1s on hand for such occasions.